Tag: Weight Loss
Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year
Impact of expanding access to GLP-1 receptor agonists, dual gastric inhibitory polypeptide and GLP-1 receptor agonists quantified
Weight Loss Durable for Years After Bariatric Surgery in Teens
Additionally, durable remission of coexisting conditions seen
Medicaid Covers GLP-1 Meds for Obesity in Just 13 States
By Dennis Thompson HealthDay Reporter
TUESDAY, Nov. 5, 2024 (HealthDay News) -- Low-income patients' access to blockbuster weight-loss drugs through Medicaid remains limited, a new...
Improvement Seen in Some Features of PCOS With Weight Loss Interventions
Interventions associated with significantly greater improvements in HOMA-IR, free androgen index, menstrual frequency
Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With Obesity
Glucagon-like peptide 1 receptor agonist prescription linked to reduction in risk for suicidal ideation or attempts
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
By Robin Foster HealthDay Reporter
TUESDAY, Oct. 15, 2024 (HealthDay News) -- Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the...
Novo Nordisk CEO Grilled by Congress Over Price of Ozempic
By Robin Foster HealthDay Reporter
WEDNESDAY, Sept. 25, 2024 (HealthDay News) -- During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO...
Cost Has Many Going Around Doctors to Get Weight-Loss Medications
By Dennis Thompson HealthDay Reporter
WEDNESDAY, Sept. 18, 2024 (HealthDay News) -- Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these...
Weight Reduction Varies for Patients Receiving Semaglutide, Liraglutide
Weight reduction at one year linked to medication active agent, dosage, treatment indication, persistence of coverage
At Least One in Five People Has Obesity in Each U.S. State
CDC data show that in 23 states, 35 percent or more of the population is now obese
